Minimus Spine, Inc. (www.minimusspine.com) announced today that has secured $1.75 million in funding from the State of Texas’ Emerging Technology Fund. The two-tranche convertible debt investment will support commercialization of its TrioJection syringe cartridge, which is intended as a non-surgical treatment for lumbar disc herniation.
“We are pleased to have the state of Texas as an investor in our company and vision.”, said David Hooper, Ph.D, Minimus Spine’s Founder and CEO. “This funding will enable us to build upon the successes we have had this year, support our first clinical work in Europe and pave the way for future growth. Austin has a strong entrepreneurial culture and is home to a number of successful spine companies. There is a great deal of local talent. We look forward to growing the business in Austin, but most importantly, improving the lives of patients with our innovative approach to ozone as a therapeutic modality.”
“Back and leg pain due to lumbar disc herniation is a huge clinical problem around the world, accounting for a significant amount of disability, pain, and lost life opportunities. How refreshing it would be if a natural substance such as ozone, introduced into the damaged disc, could be an effective alternative to pain management or reconstructive surgical interventions in these individuals. This is very exciting technology.”
Jack E. Zigler MD, FACS, FAAOS Medical Director and Spine Surgeon
Texas Back Institute
About Minimus Spine: Established in 2006, Minimus Spine is a privately held medical device company dedicated to developing its ozone technology for medical applications. The company is focused on the treatment of spinal disorders related to herniated discs. Minimus Spine is headquartered in Austin, TX. For more information on Minimus Spine, please visit http://www.minimusspine.com or email info@minimusspine.com.
“Texas continues to foster an environment that encourages world class companies and researchers to
develop technologies that have a profound impact on people’s lives around the world,” Gov. Perry said.
“Minimus Spine’s innovative medical application technology has the potential to provide a new treatment
option for spinal disorders, and further strengthens the culture of innovation we’ve fostered in the Lone
Star State,” said Texas Governor Rick Perry.